NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
Launched by UNIVERSITY OF COLORADO, DENVER · Jan 31, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The NAVIGATE Kidney trial is studying a program designed to help Latinx individuals with advanced kidney disease, specifically chronic kidney disease (CKD). The goal is to improve kidney health by reducing the use of central venous catheters (tubes used for dialysis) when starting kidney replacement therapy (KRT). The researchers believe that this program will help patients feel more involved in their care and make better decisions about their treatment.
To participate in this trial, individuals must be at least 18 years old, identify as Latino/a/x or Hispanic, and have advanced kidney disease with a specific measure of kidney function (an eGFR of 15-29). Participants can expect to be part of a program aimed at improving their kidney health and overall treatment experience. It's important to note that the trial is not yet recruiting participants, but it aims to provide valuable insights into addressing kidney health disparities in the Latinx community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults ≥ 18 years of age,
- • Adults who self-identify as Latino/e/a/x and/or Hispanic,
- • Adults who are not pregnant,
- • Adults who are not incarcerated,
- • Adults who have advanced kidney disease with an eGFR of 15-29 mL/min/1.73m2). No other measures are used to identify eligible patients.
- Exclusion Criteria:
- • Anyone who does not meet the criteria outlined above.
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Albuquerque, New Mexico, United States
Denver, Colorado, United States
Patients applied
Trial Officials
Lilia Cervantes, MD
Principal Investigator
University of Colorado-Anschutz SOM-Hospital Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported